Received: 15 November 2017
Accepted: 4 February 2018
First Online: 1 March 2018
Ethics approval and consent to participate
: The BESMILE-HF study has been approved by the Ethics Committee of the GPHCM (number: B2016–202-01). They will review the study progress at least once a year. A formal amendment to the protocol will be required, and must be approved by the Ethics Committee of the GPHCM prior to implementation, if modifications may impact on the conduct of the study, potential benefit of the patient or may affect patient safety. The BESMILE-HF study will be conducted according to the principles of the Declaration of Helsinki (2013 version). For the RCT, trained research nurses will introduce and discuss the trial information to interested patients, and a signed informed consent form will be obtained before each participant’s enrollment. Participants will be free to withdraw at any time. For the qualitative study, patients within the RCT will be recruited, and interviews and recordings will be conducted after written permission has been given.
: The participant in Fig. InternalRef removed has agreed and consented for Fig. InternalRef removed to be published.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.